Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash from Investing Activities: 2019-2025

Historic Cash from Investing Activities for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to -$386,000.

  • Burning Rock Biotech's Cash from Investing Activities rose 24.76% to -$386,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year decrease of 139.09%. This contributed to the annual value of -$604,000 for FY2024, which is 53.86% up from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's Cash from Investing Activities is -$386,000, which was up 70.85% from -$1.3 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Cash from Investing Activities registered a high of $44.0 million during Q1 2021, and its lowest value of -$20.1 million during Q3 2022.
  • For the 3-year period, Burning Rock Biotech's Cash from Investing Activities averaged around -$1.6 million, with its median value being -$591,000 (2023).
  • Per our database at Business Quant, Burning Rock Biotech's Cash from Investing Activities soared by 8,600.12% in 2021 and then slumped by 4,170.97% in 2025.
  • Quarterly analysis of 5 years shows Burning Rock Biotech's Cash from Investing Activities stood at -$10.5 million in 2021, then skyrocketed by 93.05% to -$730,000 in 2022, then spiked by 93.70% to -$46,000 in 2023, then slumped by 141.30% to -$111,000 in 2024, then increased by 24.76% to -$386,000 in 2025.
  • Its last three reported values are -$386,000 in Q3 2025, -$1.3 million for Q2 2025, and -$1.5 million during Q1 2025.